ASX - By Stock
|
PRN |
Re:
Ann: Perenti operational update
|
|
Bent_Brent
|
79 |
42K |
8 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
79
|
42K
|
8
|
|
ASX - By Stock
|
VOC |
Re:
Ann: Vocus enters into Scheme Implementation Deed
|
|
Bent_Brent
|
22 |
10K |
4 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
22
|
10K
|
4
|
|
ASX - By Stock
|
CLH |
Re:
Who are the Buyers?
|
|
Bent_Brent
|
42 |
49K |
0 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
42
|
49K
|
0
|
|
ASX - By Stock
|
CLH |
Re:
Who are the Buyers?
|
|
Bent_Brent
|
42 |
49K |
3 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
42
|
49K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Bent_Brent
|
108 |
35K |
10 |
04/11/20 |
04/11/20 |
ASX - By Stock
|
108
|
35K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
What are the positives?
|
|
Bent_Brent
|
65 |
20K |
8 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
65
|
20K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Approval for first-in-human study
|
|
Bent_Brent
|
70 |
21K |
2 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
70
|
21K
|
2
|
|
ASX - By Stock
|
CLH |
Re:
Ann: Suspension from Official Quotation
|
|
Bent_Brent
|
59 |
504K |
6 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
59
|
504K
|
6
|
|
ASX - By Stock
|
GEM |
Re:
Ann: FY19 Results Investor Presentation
|
|
Bent_Brent
|
7 |
9.0K |
5 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
7
|
9.0K
|
5
|
|
ASX - By Stock
|
CLH |
Re:
Ann: Trading Halt
|
|
Bent_Brent
|
61 |
185K |
0 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
61
|
185K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Bent_Brent
|
43 |
18K |
0 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
43
|
18K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Bent_Brent
|
43 |
18K |
2 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
43
|
18K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Proposal to be considered at EGM
|
|
Bent_Brent
|
122 |
66K |
8 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
122
|
66K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Bent_Brent
|
289 |
132K |
9 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
289
|
132K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Musings of a ‘mug’ RI playing the Stockmarket.
|
|
Bent_Brent
|
63 |
28K |
4 |
10/10/19 |
10/10/19 |
ASX - By Stock
|
63
|
28K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Market entry / milestone dates
|
|
Bent_Brent
|
58 |
27K |
2 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
58
|
27K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
7 |
5.7K |
1 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
7
|
5.7K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fee
|
|
Bent_Brent
|
55 |
31K |
1 |
22/08/19 |
22/08/19 |
ASX - By Stock
|
55
|
31K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fee
|
|
Bent_Brent
|
55 |
31K |
2 |
22/08/19 |
22/08/19 |
ASX - By Stock
|
55
|
31K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
40 |
18K |
2 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
40
|
18K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
40 |
18K |
2 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
40
|
18K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
40 |
18K |
14 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
40
|
18K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Bent_Brent
|
63 |
39K |
11 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
63
|
39K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Bent_Brent
|
63 |
39K |
17 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
63
|
39K
|
17
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
38 |
21K |
0 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
38
|
21K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
38 |
21K |
0 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
38
|
21K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
38 |
21K |
2 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
38
|
21K
|
2
|
|
ASX - By Stock
|
LRS |
Re:
Ann: Ceasing to be a substantial holder
|
|
Bent_Brent
|
13 |
5.6K |
4 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
13
|
5.6K
|
4
|
|
ASX - By Stock
|
LRS |
Re:
Ann: Ceasing to be a substantial holder
|
|
Bent_Brent
|
13 |
5.6K |
2 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
13
|
5.6K
|
2
|
|
ASX - By Stock
|
LRS |
Re:
Ann: Response to ASX Query Letter
|
|
Bent_Brent
|
27 |
12K |
8 |
20/07/19 |
20/07/19 |
ASX - By Stock
|
27
|
12K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Bent_Brent
|
314 |
125K |
15 |
04/06/19 |
04/06/19 |
ASX - By Stock
|
314
|
125K
|
15
|
|
ASX - By Stock
|
AVR |
Re:
I read it on Face Book
|
|
Bent_Brent
|
13 |
6.7K |
2 |
29/05/19 |
29/05/19 |
ASX - By Stock
|
13
|
6.7K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
TAVR; the potential of Admedus being part of.
|
|
Bent_Brent
|
45 |
16K |
17 |
27/05/19 |
27/05/19 |
ASX - By Stock
|
45
|
16K
|
17
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Facility Agreement with SIO Partners LP
|
|
Bent_Brent
|
94 |
31K |
10 |
09/05/19 |
09/05/19 |
ASX - By Stock
|
94
|
31K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
Bent_Brent
|
170 |
65K |
3 |
17/04/19 |
17/04/19 |
ASX - By Stock
|
170
|
65K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Under the Radar
|
|
Bent_Brent
|
538 |
233K |
8 |
09/04/19 |
09/04/19 |
ASX - By Stock
|
538
|
233K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval
|
|
Bent_Brent
|
567 |
353K |
2 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
567
|
353K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval
|
|
Bent_Brent
|
567 |
353K |
10 |
12/03/19 |
12/03/19 |
ASX - By Stock
|
567
|
353K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Promising Interim Results from TAVR Animal Study
|
|
Bent_Brent
|
63 |
27K |
1 |
19/02/19 |
19/02/19 |
ASX - By Stock
|
63
|
27K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
A new Beginning...
|
|
Bent_Brent
|
3.4K |
1.9M |
3 |
14/02/19 |
14/02/19 |
ASX - By Stock
|
3.4K
|
1.9M
|
3
|
|
ASX - By Stock
|
AVR |
Farewell, punks
|
|
Bent_Brent
|
106 |
48K |
36 |
21/01/19 |
21/01/19 |
ASX - By Stock
|
106
|
48K
|
36
|
|
ASX - By Stock
|
AVR |
Re:
No news
|
|
Bent_Brent
|
12 |
5.8K |
3 |
18/01/19 |
18/01/19 |
ASX - By Stock
|
12
|
5.8K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Top 20 list public document
|
|
Bent_Brent
|
46 |
16K |
3 |
15/01/19 |
15/01/19 |
ASX - By Stock
|
46
|
16K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Who's in and who's out
|
|
Bent_Brent
|
69 |
24K |
2 |
10/12/18 |
10/12/18 |
ASX - By Stock
|
69
|
24K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AHZ Technical Analysis
|
|
Bent_Brent
|
205 |
76K |
6 |
02/12/18 |
02/12/18 |
ASX - By Stock
|
205
|
76K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus launches rights issue
|
|
Bent_Brent
|
250 |
85K |
14 |
30/11/18 |
30/11/18 |
ASX - By Stock
|
250
|
85K
|
14
|
|
ASX - By Stock
|
AVR |
New Shareholder Prospectus
|
|
Bent_Brent
|
7 |
1.9K |
25 |
30/11/18 |
30/11/18 |
ASX - By Stock
|
7
|
1.9K
|
25
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus launches rights issue
|
|
Bent_Brent
|
250 |
85K |
6 |
30/11/18 |
30/11/18 |
ASX - By Stock
|
250
|
85K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
General commentary in reference to resume of trading.
|
|
Bent_Brent
|
57 |
22K |
6 |
29/11/18 |
29/11/18 |
ASX - By Stock
|
57
|
22K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus launches rights issue
|
|
Bent_Brent
|
250 |
85K |
4 |
28/11/18 |
28/11/18 |
ASX - By Stock
|
250
|
85K
|
4
|
|